Skip to content

美拉基因治疗

US · MGTX #3220 按市值排名 上市于 2018
9.28 -0.61 -6.17%
实时 - 追踪5344个代码 - 心跳于47秒前 · 2026-10-16 20:02

最新新闻

  • 评级变动
    Chardan Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $35
    \u5e02\u573a\u8d44\u8baf · 2026/5/15
  • 评级变动
    Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $30
    \u5e02\u573a\u8d44\u8baf · 2026/4/22
  • 评级变动
    RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $16
    \u5e02\u573a\u8d44\u8baf · 2026/3/27
  • 评级变动
    Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20
    \u5e02\u573a\u8d44\u8baf · 2025/12/19
  • 评级变动
    RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $26
    \u5e02\u573a\u8d44\u8baf · 2026/7/9
  • 评级变动
    Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $18
    \u5e02\u573a\u8d44\u8baf · 2026/4/1
  • 评级变动
    BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $14
    \u5e02\u573a\u8d44\u8baf · 2026/1/6
  • 评级变动
    H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $26
    \u5e02\u573a\u8d44\u8baf · 2026/3/27
  • RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $27
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • A Quick Look at Today's Ratings for MeiraGTx Holdings(MGTX.US), With a Forecast Between $19 to $30
    \u5e02\u573a\u8d44\u8baf · 2026/7/8
  • 评级变动
    RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $24
    \u5e02\u573a\u8d44\u8baf · 2026/4/17
  • 评级变动
    RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $25
    \u5e02\u573a\u8d44\u8baf · 2026/5/15
  • Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $30
    \u5e02\u573a\u8d44\u8baf · 2026/8/17
  • 评级变动
    H.C. Wainwright Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20
    \u5e02\u573a\u8d44\u8baf · 2025/11/24
  • Goldman Sachs Initiates MeiraGTx Holdings(MGTX.US) With Hold Rating, Announces Target Price $16
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $19
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $20
    \u5e02\u573a\u8d44\u8baf · 2025/12/18
  • 评级变动
    Cantor Fitzgerald Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20
    \u5e02\u573a\u8d44\u8baf · 2026/7/9
  • 评级变动
    BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $16
    \u5e02\u573a\u8d44\u8baf · 2026/3/27

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

美拉基因治疗 讨论区 0 条评论

发表评论